DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS (Q2035310): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS., Adding English summary) |
(Changed an Item) |
||
| Property / programme | |||
| Property / programme: Lazio - ERDF / rank | |||
Normal rank | |||
Revision as of 05:48, 24 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS |
Project in Italy financed by DG Regio |
Statements
183,393.18 Euro
0 references
366,786.35 Euro
0 references
50.0 percent
0 references
13 December 2016
0 references
6 July 2019
0 references
UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
0 references
KAY SYSTEMS ITALIA SRL
0 references
41°53'35.95"N, 12°28'58.55"E
0 references
LA RADIOTERAPIA MOLECOLARE, INDICATA IN MOLTE NEOPLASIE, IMPIEGA RADIONUCLIDI COME SORGENTI NON SIGILLATE (SPESSO RADIOFARMACI) PER RILASCIARE RADIAZIONI E DISTRUGGERE CELLULE NEOPLASTICHE. (Italian)
0 references
THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS. (English)
0 references
Identifiers
F87H18000440007
0 references